Drug Design I

Catalog description

The first course in a three-semester sequence provides an overview of the pharmaceutical industry and the drug development process, followed by an in-depth study of the clinical trials portion of the process. Statistical design used in trials for demonstrating drug safety and efficacy are discussed. The role of IRBs, informed consent, and other medical legal issues are explored.